BridgeBio Oncology Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -49,000 | -29,912 | -23,083 | -21,827 |
EBIT | -49,181 | -30,093 | -23,137 | -21,879 |
Net Income | -44,757 | -28,435 | -22,055 | -19,687 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -71,159 | -23,524 | -734 | -87 |
Cash | 408,741 | 31,518 | 963 | 1,697 |
Basic Shares | 23,509 | 23,509 | 23,509 | 16,636 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -80,655 | -64,679 |
EBIT | -80,863 | -64,771 |
Net Income | -74,275 | -64,699 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -763 | -52,493 |
Cash | 1,697 | 250 |
Basic Shares | 16,636 | 20,485 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.03 |
2025-06-30 | $0.03 |
2025-03-31 | -$0.02 |
2024-12-31 | $0.08 |
